Role of staphylococcal superantigens in atopic dermatitis: From colonization to inflammation

Annals of Allergy, Asthma and Immunology

Volumn 84, Issue 1, 2000, Pages 3-12

  Taskapan, Mehmet Oktay ^a   Kumar, Prem ^b  

^a GATA HAYDARPASA TRAINING HOSPITAL   (Turkey)

^b LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; BACTERIAL ANTIGEN; CHLORHEXIDINE; CLOXACILLIN; CYTOKINE; EMOLLIENT AGENT; ERYTHROMYCIN; FLUCLOXACILLIN; LYMPHOCYTE ANTIGEN; SUPERANTIGEN; T LYMPHOCYTE RECEPTOR; TRICLOSAN;

ALLERGENICITY; ANTIGEN PRESENTING CELL; ANTIGENICITY; APOPTOSIS; ATOPIC DERMATITIS; BACTERIAL COLONIZATION; CELL STIMULATION; HUMAN; KERATINOCYTE; LYMPHOCYTE PROLIFERATION; PRIORITY JOURNAL; REVIEW; SKIN INFECTION; SKIN INFLAMMATION; STAPHYLOCOCCUS AUREUS; T LYMPHOCYTE; ULTRAVIOLET IRRADIATION;

EID: 0033953345     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)62731-7     Document Type: Review

References (60)

1. Leung DYM. Atopic dermatitis: the skin as a window into the pathogenesis of chronic allergic diseases. J Allergy Clin Immunol 1995;96(3):302-318.
2. Rudikoff D, Lebwohl M. Atopic dermatitis. Lancet 1998;351:1715-1721.
3. Wuthrich B. Atopic dermatitis flare provoked by inhalant allergens. Dermatologica 1989;178:51-53.
4. Thestrup-Pedersen K, Ellingsen AR, Olesen AB, et al. Atopic dermatitis may be a genetically determined dysmaturation of ectodermal tissue, resulting in disturbed T-lymphocyte maturation. Acta Derm Venereol (Stockh) 1997;77:2021.
5. Werfel T, Kapp A. Environmental and other major provocation factors in atopic dermatitis. Allergy 1998;53: 731-739.
6. Williams HC, Strachan DP, Roderick JH. Childhood eczema: disease of the advantaged? Br Med J 1994;308: 1132-1135.
7. Taskapan O, Ozanguc N. Atopik dermatit: patogenez ve tedavide yeni yaklasimlar. Deri Hast Frengi Ars (Turkderm) 1995;29(3-4):139-146.
8. Leung DYM, Rhodes AR, Geha RS, et al. Atopic dermatitis. In: Fitzpatrick TB, Eisen AZ, Wolff K, Freedberg IM, Austen KF, eds. Dermatology in general medicine. 4th edition, New York: McGraw-Hill, Inc., 1993:1543-1564.
9. Ostlere LS, Gordon DJ, Ayliffe MJ, et al. Substance P binding to peripheral blood mononuclear leukocytes in atopic dermatitis. Acta Derm Venereol (Stockh) 1997;77:260-263. Leung DYM. Atopic Dermatitis: The skin as a window into the pathogenesis of chronic allergic diseases. J Allergy Clin Immunol 1995;96(3):302-318.
10. Ostlere LS, Gordon DJ, Ayliffe MJ, et al. Substance P binding to peripheral blood mononuclear leukocytes in atopic dermatitis. Acta Derm Venereol (Stockh) 1997;77:260-263. Leung DYM. Atopic Dermatitis: The skin as a window into the pathogenesis of chronic allergic diseases. J Allergy Clin Immunol 1995;96(3):302-318.
11. Valenta R, Maurer D, Steiner R, et al. Immunoglobulin E response to human proteins in atopic patients. J Invest Dermatol 1996;107:203-208.
12. Norris DA, Leung DYM. Superantigens in inflammatory skin diseases. In: Leung DYM, Huber BT, Schlievert PM, eds. Superantigens: Molecular biology, immunology, and relevance to human disease. New York: Marcel Dekker Inc, 1997;551-579.
13. Leung DYM, Hauk P, Strickland I, et al. The role of superantigens in human diseases: therapeutic implications for the treatment of skin diseases. Br J Dermatol 1998;139:17-29.
14. Leyden JJ, Marples RR, Kligman AM. Staphylococcus aureus in the lesions of atopic dermatitis. Br J Dermatol 1974;90:525-530.
15. Lever R, Hadley K, Downey D, MacKie R. Staphylococcal colonization in atopic dermatitis and the effect of topical mupirocin therapy. Br J Dermatol 1988;119:189-198.
16. Rosen H. Superantigens. Int J Dermatol 1997;36:14-16.
17. Skov L, Baadsgaard O. Superantigens: do they have a role in skin diseases? Arch Dermatol 1995;131:829-832.
18. White J, Herman A, Pullen AM, et al. The Vβ-specific superantigen staphylococcal enterotoxin B: stimulation of mature T cells and clonal deletion in neonatal mice. Cell 1989;56:27-35.
19. Kotzin BL. Superantigens and their role in disease. Hosp Pract 1994;Nov. 15:59-70.
20. Manders SM. Toxin-mediated streptococcal and staphylococcal disease. J Am Acad Dermatol 1998;39: 383-398.
21. Schlievert PM. Role of superantigens in human disease. J Infect Dis 1993; 167:997-1002.
22. Leung DYM, Huber BT, Schlievert PM. Historical perspective of superantigens and their biological activities. In: Leung DYM, Huber BT, Schlievert PM, eds. Superantigens: molecular biology, immunology, and relevance to human disease. New York: Marcel Dekker, Inc., 1997:1-3.
23. Thestrup-Pedersen K. Bacteria and the skin: clinical practice and therapy update. Br J Dermatol 1998;139:1-3.
24. McGinley KJ, Leyden JJ, Marples RR, Kligman AM. Quantitative microbiology of the scalp in non-dandruff, dandruff, and seborrheic dermatitis. J Invest Dermatol 1975;64:401-405.
25. Leyden JJ, Kligman AM. The case for steroid-antibiotic combinations. Br J Dermatol 1977;96:179-187.
26. Leyden JJ. Mupirocin: A new: a new topical antibiotic. J Am Acad Dermatol 1990;22:879-883.
27. Duvic M. Human immunodeficiency virus and the skin: selected controversies. J Invest Dermatol 1995;105: 117S-121S.
28. Boguniewicz M, Leung DYM. Atopic dermatitis: a question of balance. Arch Dermatol 1998;134:870-871.
29. Grewe M, Walther S, Gyufko K, et al. Analysis of the cytokine pattern expressed in situ in inhalant allergen patch test reactions of atopic dermatitis patients. J Invest Dermatol 1995;105: 407-410.
30. Noble WC. Skin bacteriology and the role of staphylococcus aureus in infection. Br J Dermatol 1998;139:9-12.
31. Schlievert PM, Blomster DA. Production of staphylococcal pyrogenic exotoxin type C: influence of physical and chemical factors. J Infect Dis 1983; 147:236-242.
32. Strange P, Skov L, Lisby S, et al. Staphylococcal enterotoxin B applied on intact normal and intact atopic skin induces dermatitis. Arch Dermatol 1996;132:27-33.
33. Michie CA, Davis T. Atopic Dermatitis and staphylococcal superantigens [letter]. Lancet 1996;347:324.
34. Nissen D, Pedersen LJ, Skov PS, et al. IgE binding components of staphylococcal enterotoxins in patients with atopic dermatitis. Ann Allergy Asthma Immunol 1997;79:403-408.
35. Leung DYM, Gately M, Trumble A, et al. Bacterial superantigens induce T cell expression of the skin-selective homing receptor, the cutaneous lymphocyte-associated antigen, via stimulation of IL-12 production. J Exp Med 1995;181:747-753.
36. Abeck D, Mempel M. Staphylococcus aureus colonization in atopic dermatitis and its therapeutic implications. Br J Dermatol 1998;139:13-16.
37. Ezepchuk YV, Leung DYM, Hiddleton MH, et al. Staphylococcal toxins and protein A differentially induce cytotoxicity and release of tumor necrosis factor-α from human keratinocytes. J Invest Dermatol 1996;107:603-609.
38. Hofer MF, Lester MR, Schlievert PM, Leung DYM. Upregulation of IgE synthesis by staphylococcal toxic shock syndrome toxin-1 in peripheral blood mononuclear cells from patients with atopic dermatitis. Clin Exp Allergy 1995;25:1218-1227.
39. Jun Ha S, Jeong Lee H, Gyoo Byun D, Wou Kim J. Expression of T cell receptor Vβ chain in lesional skin of atopic dermatitis. Acta Derm Venereol (Stockh) 1998;78:424-427.
40. Hofer MF, Newell K, Duke RC, Schlievert PM, et al. Differential effects of staphylococcal toxic shock syndrome toxin-1 on B cell apoptosis. Proc Natl Acad Sci USA 1996;93: 5425-5430.
41. May KR, Leung DYM, Doherty DE, Bratton DL. Staphylococcal toxic shock syndrome toxin-1 reduces apoptosis of monocytes in atopic dermatitis. J Allergy Clin Immunol 1999; 103(5 pt 1):895-900.
42. Saloga J, Leung DYM, Reardon C, et al. Cutaneous exposure to the superantigen staphylococcal enterotoxin B elicits a T cell-dependent inflammatory response. J Invest Dermatol 1996; 106:982-988.
43. Abernathy-Carver K, Sampson H, Pivker L, Leung DYM. Milk-induced eczema is associated with the expansion of T cells expressing cutaneous lymphocyte antigen. J Clin Invest 1995;95: 913-918.
44. Leung DYM, Cotran RS, Pober JS. Expression of an endothelial leukocyte adhesion molecule (ELAM-1) in elicited late phase allergic skin reactions. J Clin Invest 1991;87:1805-1810.
45. Leung DYM, Harbeck R, Bina P, et al. Presence of IgE antibodies to staphylococcal exotoxins on the skin of patients with atopic dermatitis: Evidence for a new group of allergens. J Clin Invest 1993;92:1374-1380.
46. Bunikowski R, Mielke M, Skarabis H, et al. Prevalance and role of serum IgE antibodies to the staphylococcus aureus-derived superantigens SEA and SEB in children with atopic dermatitis. J Allergy Clin Immunol 1999;103(1): 119-124.
47. Nomura I, Tanaka K, Tomita H, et al. Evaluation of the staphylococcal exotoxins and their specific IgE in childhood atopic dermatitis. J Allergy Clin Immunol 1999;104(2 pt 1):441-446.
48. Bratton DL, Hamid Q, Boguniewicz M, et al. Granulocyte macrophage-colony stimulating factor inhibition of monocyte apoptosis contributes to the chronic monocyte activation in atopic dermatitis. J Clin Invest 1995;95: 211-218.
49. Jappe U, Heuck D, Witte W, Gollnick H. Superantigen production by staphylococcus aureus in atopic dermatitis: no more than a coincidence? J Invest Dermatol 1998;110(5):844-846.
50. Zollner TM, Kaufman R. Superantigens in T cell-mediated skin diseases - more than a coincidence! J Invst Dermatol 1999;112(1):118-119.
51. Hoeger PH, Lenz W, Boutonnier A, Fournier JM. Staphylococcal skin colonization in children with atopic dermatitis: prevalance, persistence, and transmission of toxigenic and nontoxigenic strains. J Infec Dis 1992;165: 1064-1068.
52. Dhar S, Kanwar AJ, Kaur S, et al. Role of bacterial flora in the pathogenesis & management of atopic dermatitis. Indian J Med Res 1992;95:234-238.
53. David TJ, Cambridge GC. Bacterial infection and atopic eczema. Arch Dis Child 1986;61:20-23.
54. Ring J, Brockow K, Abeck D. The therapeutic concept of patient management in atopic eczema. Allergy 1996; 51:206-215.
55. Lever R. Infection in atopic dermatitis. Derm Ther 1997;1:32-37.
56. Lewing C, Ashcroft C, Gibbs ACC, et al. Flucloxacillin in the treatment of atopic dermatitis. Br J Dermatol 1998; 138:1022-1029.
57. Stalder JF, Fleury M, Sourisse M, et al. Comparative effects of two topical antiseptics (chlorhexidine vs KMnO4) on bacterial skin flora in atopic dermatitis. Acta Derm Venereol (Stockh) 1992(Suppl)176:132-134.
58. Gehring W, Forssman TH, Jost G, Gloor M. Die keimreduzierende wirkung von erythromycin und triclosan bei der atopischen dermatitis. Akt Dermatol 1996;22:28-31.
59. Krutman J. Phototherapy for atopic dermatitis. Dermatol Ther 1996;1: 24-31.
60. Yoshimura M, Namura S, Akamatsu H, Horio T. Antimicrobial effects of phototherapy and photochemotherapy in vivo and in vitro. Br J Dermatol 1996;135:528-532.